Substance Use Disorder

News

Pear extends digital therapeutics partnership with Spero

Addiction treatment specialist Spero Health has expanded an agreement to use Pear Therapeutics’ prescription digital therapeutics (DTx) in its network of US clinics.

News

Digital health firm Pear goes public, raising $175 million

Pear Therapeutics has completed its merger with blank cheque company Thimble Point Acquisition Corp, claiming a Nasdaq listing and raising $175 million in gross proceeds for the digital hea

News

Novartis and Pear to develop substance use digital therapeut...

Novartis is set to develop and commercialise a range of digital therapeutics for patients with substance and opioid use disorders as it expands its work with Pear Therapeutics through a dea

News

syringe studio shoot in white background

IBM Watson enlisted to combat substance abuse

Watson will be used to improve prevention of Substance Use Disorder relapses.

Pear extends digital therapeutics partnership with Spero

Digital health firm Pear goes public, raising $175 million

Novartis and Pear to develop substance use digital therapeut...

IBM Watson enlisted to combat substance abuse

US pharma tariffs of up to 100% finalised by Trump

Using AI-driven synthetic personas to take your insights fur...

Substance Use Disorder

Editor's Picks